Atelerix

Founded in 2017, Atelerix is an innovative biotechnology company specialising in ambient preservation technologies for cells, tissues, blood samples and advanced cell models. The company's proprietary hydrogel-based encapsulation technology enables biological materials to be transported and stored at ambient temperatures, eliminating the need for cryopreservation, dry ice and complex cold-chain logistics.

Atelerix develops solutions that help researchers preserve sample viability, functionality and quality while reducing shipping costs, increasing workflow flexibility and supporting more sustainable laboratory practices. The company's product portfolio includes CytoStor™ for cells, viral vectors and lipid nanoparticles, LeukoStor™ for leukapheresis preservation, TissueReady Plus™ for fresh tissue samples, STORganoid™ for organoids and spheroids, and BloodReady™ for blood-derived samples.  The company’s technologies support the handling, distribution and downstream analysis of valuable biological samples while helping researchers maintain sample quality across geographically distributed studies and manufacturing processes. Operating under an ISO 9001:2015-certified quality management system, Atelerix develops preservation solutions designed to support reproducible research and therapeutic development.

Europa Biosite's subsidiaries distribute for Atelerix in Austria, Belgium, Canada, Denmark, Estonia, Finland, Germany, Iceland, Ireland, Latvia, Lithuania, Luxemburg, Netherlands, Norway, Sweden, Switzerland, United Kingdom and the USA.